Intellia Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$8.82
Previous Close
$8.87
Day Range
$8.50-$8.85
52W Range
$5.90-$28.18
Market Cap
$918.1M
Shares Short
28M

Financials

See more
Revenue (12 Mos)
$57.8M
Revenue Growth (YoY)
-24%
Gross Profit (12 Mos)
-$408.4M
Diluted EPS
-$5.25

News

See more

Yahoo Finance • 16 days ago

Intellia Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – NTLA

Yahoo Finance • 17 days ago

NTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intellia Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Yahoo Finance • 18 days ago

NTLA Investors Have the Opportunity to Lead the Intellia Therapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

Yahoo Finance • 19 days ago

NTLA DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action – NTLA

About

CEO
Dr. John M. Leonard M.D.
Address
40 Erie Street, Cambridge, MA, United States, 02139
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
403